Mark R Nehler
5PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 23, 2025
Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.Shea Hogan, Michael Szarek, E Sebastian Debus
|Jan 27, 2025
Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial.Connie N Hess, Ashley Daffron, Mark R Nehler
|Feb 16, 2022
Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.Scott D Berkowitz, Rupert M Bauersachs, Michael Szarek
|Aug 31, 2021
Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.Sonia S Anand, Will Hiatt, Leanne Dyal
|Aug 25, 2021
Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.Mori J Krantz, Sebastian E Debus, Judith Hsia
Pageof 1
Frequent Collaborators
5 joint publications
Michael Szarek
5 joint publications
Marc P Bonaca
4 joint publications
Rupert M Bauersachs
4 joint publications
Scott E Berkowitz
3 joint publications
Sonia S Anand
3 joint publications
Judy Hsia
3 joint publications
Connie N Hess
2 joint publications
Lloyd P Haskell
2 joint publications
E Sebastian Debus
2 joint publications
Manesh R Patel
